Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Potential late second dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (received 1st dose on an unknown date). On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: Potential late second dose). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 17-JAN-2025 The reporter contacted via web chat anonymous started conversation mentioning was it acceptable to administer 2 dose of shingles greater than 6 months after 1st. The healthcare provider abandoned the chat right after agent asked for consent to store contact details into the database, without any additional data about the case. It was not clarified if a patient was involved or if it was just a hypothetical question, and if the vaccine was Shingrix. The agent did not have a chance to ask for consent to follow up with safety team. Till the time of reporting, the patient did not receive 2nd dose of Shingles vaccine which led to incomplete course of vaccination.